SLAI:NYSESOLAI Limited Analysis
Data as of 2026-09-01 - not real-time
$3.72
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $3.72, SOLAI Limited shows no decisive moving-average alignment, leaving the trend neutral.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 20.1% on a -134.6% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With a beta of 3.03, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 20.1% on a -134.6% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With a beta of 3.03, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...AKRON, Ohio, July 21, 2026 /PRNewswire/ -- SOLAI Limited NYSE: SLAI "SOLAI" or the "Company" previously known as "BIT...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Beta of 3.03 versus the benchmark
- Thin trading liquidity raises execution risk
- Price-to-book of 2.51
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Beta of 3.03 versus the benchmark
- Thin trading liquidity raises execution risk
- Negative profit margin of -134.6%
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative profit margin of -134.6%
- Negative return on equity of -69.3%
- Revenue growth of +20.1%
Key Metrics & Analysis
Financial Health
Revenue Growth20.10%
Profit Margin-134.63%
P/E Ratio-186.0
ROE-69.29%
ROA-26.17%
Debt/Equity5.55
P/B Ratio2.5
Industry P/E35.3
Technical Analysis
TrendNeutral
MACDNeutral
VolumeStable
Fear & Greed Index92.25
Valuation
GradeFair
TypeGrowth
Risk Assessment
Beta3.03
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.